InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Brooks Gabriel. Director active across 1 company, notably Solid Biosciences Inc.. Cumulatively, 5 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €32k. History available since 21 October 2024. The latest transaction was disclosed on 20 October 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
5 of 5 declarations